Genetic variability in the multidrug resistance associated protein-1 (ABCC1/MRP1) predicts hematological toxicity in breast cancer patients receiving (neo-)adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide (FEC).
about
Candidate Gene Association Studies of Anthracycline-induced Cardiotoxicity: A Systematic Review and Meta-analysis.Non-coding polymorphisms in nucleotide binding domain 1 in ABCC1 gene associate with transcript level and survival of patients with breast cancer.Therapeutic strategies for chemotherapy-induced neutropenia in patients with solid tumors.Multivariable regression analysis of febrile neutropenia occurrence in early breast cancer patients receiving chemotherapy assessing patient-related, chemotherapy-related and genetic risk factorsSalinomycin enhances doxorubicin-induced cytotoxicity in multidrug resistant MCF-7/MDR human breast cancer cells via decreased efflux of doxorubicin.Curcumin Improves the Tumoricidal Effect of Mitomycin C by Suppressing ABCG2 Expression in Stem Cell-Like Breast Cancer Cells.Genetic variation of the ABC transporter gene ABCC1 (Multidrug resistance protein 1-MRP1) in the Polish populationImportance of ABCC1 for cancer therapy and prognosis.Prognostic information of a previously diagnosed sister is an independent prognosticator for a newly diagnosed sister with breast cancer.MRP1 and its role in anticancer drug resistance.Advances and challenges in hereditary cancer pharmacogenetics.Exploratory analysis of candidate germline gene polymorphisms in breast cancer patients treated with neoadjuvant anthracycline-containing chemotherapy and associations with febrile neutropenia.Clinical validation of genetic variants associated with in vitro chemotherapy-related lymphoblastoid cell toxicity.Impact of genetic variability and treatment-related factors on outcome in early breast cancer patients receiving (neo-) adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide, and docetaxel.Clinical and genetic risk factors for epirubicin-induced cardiac toxicity in early breast cancer patients.Independent replication of polymorphisms predicting toxicity in breast cancer patients randomized between dose-dense and docetaxel-containing adjuvant chemotherapy.General adverse response to cyclophosphamide in Chinese patients with systemic autoimmune diseases in recent decade—a single-center retrospective study.Impact of ABC single nucleotide polymorphisms upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia.
P2860
Q33671281-B1E0DB23-CE04-4FBD-88F4-BE3F642AD28AQ33982601-CEC3E35C-1705-44F2-B554-FEC32ADDAD49Q34670717-9AD36C8F-CCA9-4EAC-BE26-1694BE12C17EQ35123683-13EE478E-ABD4-4376-8D02-8493B1970271Q35609552-197FFDFE-84AC-431B-8D44-BAA316752F60Q35754947-2F977670-48BD-414C-93F0-9B2797741FB4Q35784144-678663D8-7F38-4142-81DF-A0993B0ACBA0Q38199535-2BAACC0F-2F9D-4883-9304-2F22C41261F8Q38419595-A72A207D-A58B-44BE-9D23-489F6A52F3EBQ38626237-752EC09D-6E9E-428C-9CBD-3310196CC7A8Q38948499-20F7A3DF-E2B5-4AC7-B307-A9E12D8923E9Q41469853-F8811340-107B-45B6-A0A4-5FB3792F6801Q45746480-C2F0158D-CC35-46DE-9215-0B4693108612Q49049921-231F56D5-C8C9-495E-B83B-58061661DC9CQ49136273-F30C845D-688F-4C1C-AFE3-BB7F04E96266Q49678698-E0AC697D-B853-4DED-8FBA-79D9A134F20EQ51125568-D6AFEA46-389E-4AD6-B100-B7E8D1851B01Q51782486-0C934FD3-0081-4CD3-8160-CC21E4C91F2F
P2860
Genetic variability in the multidrug resistance associated protein-1 (ABCC1/MRP1) predicts hematological toxicity in breast cancer patients receiving (neo-)adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide (FEC).
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Genetic variability in the mul ...... in and cyclophosphamide (FEC).
@ast
Genetic variability in the mul ...... in and cyclophosphamide (FEC).
@en
type
label
Genetic variability in the mul ...... in and cyclophosphamide (FEC).
@ast
Genetic variability in the mul ...... in and cyclophosphamide (FEC).
@en
prefLabel
Genetic variability in the mul ...... in and cyclophosphamide (FEC).
@ast
Genetic variability in the mul ...... in and cyclophosphamide (FEC).
@en
P2093
P356
P1433
P1476
Genetic variability in the mul ...... in and cyclophosphamide (FEC).
@en
P2093
A Dieudonné
B Brouwers
C Vulsteke
H Wildiers
P Schöffski
R Paridaens
T van Brussel
P304
P356
10.1093/ANNONC/MDT008
P577
2013-02-07T00:00:00Z